Moneycontrol PRO
HomeNewsBusinessStocksBuy Dr. Reddy’s Laboratories; target of Rs 6373 Sharekhan

Buy Dr. Reddy’s Laboratories; target of Rs 6373 Sharekhan

Sharekhan is bullish on Dr. Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 6373 in its research report dated December 07, 2023.

December 08, 2023 / 13:06 IST
Buy
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Sharekhan's research report on Dr. Reddy’s Laboratories

    Dr Reddy’s Laboratories has entered into an agreement for the development and commercialisation of COYA 302, an investigational combination therapy for the treatment of Amyotrophic Lateral Sclerosis (ALS). Dr. Reddy’s will make a USD 7.5 million upfront payment to Coya. Coya is also eligible to receive sales-based milestone payments of up to USD 677.25 million linked to tiers of cumulative net sales achieved over several years (over the term of the agreement subject to product commercial exclusivity). Under the Agreement, Dr. Reddy’s will obtain commercialization rights for COYA 302 in the United States, Canada, the European Union and the United Kingdom for patients with ALS.

    Outlook

    Management retains its strong guidance of over 25% EBITDA margin in the near term, driven by settled product agreements like gRevlimid and double-digit growth in the India business. The stock trades at an attractive valuation of 17.3x and 15.4x its FY2025E and FY2026E estimates vs. peers’ 26x and 22.1x, indicating attractive valuations. Hence we maintain BUY with PT of Rs. 6,373.

    For all recommendations report, click here

    Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    Dr. Reddy’s Laboratories - 08 - 11 - 2023 - khan

    Broker Research
    first published: Dec 8, 2023 01:06 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347